| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |